Clinical Trials Browser

Terminated × Lymphoma, B-Cell, Marginal Zone × Gemcitabine × Clear all

NCT03432741 2025-05-26

Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer

Phase 1 Terminated

BreastDermatologicLymphoid

Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone

NCT00337259 2016-02-17

Gemcitabine for Marginal Zone Lymphoma

Phase 2 Terminated

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Marginal Zone